|
Press Releases |
|
 |
|
Thursday, April 3, 2025 |
|
卫龙美味公布2024年全年业绩 |
中国辣味休闲食品行业龙头企业,卫龙美味全球控股有限公司("卫龙美味"或"集团")及附属公司("集团")(香港联交所股票代码:09985)公布截至2024年12月31日止12个月("年内")之全年业绩。 more info >> |
|
Friday, March 28, 2025 |
|
WL Delicious Announced 2024 Annual Results |
In 2024, facing a complex and challenging domestic and international environment, China's consumer market continued to experience rapid and dynamic changes. WL Delicious gained deep consumer insights, focused on the multi-category product strategy, and continued to advance its omni-channel strategy and brand development. more info >> |
|
卫龙美味公佈2024年全年業績 |
中國辣味休閒食品行業龍頭企業,卫龙美味全球控股有限公司(“卫龙美味”或“集團”)及附屬公司(“集團”)(香港聯交所股票代碼:09985)公佈截至2024年12月31日止12個月(“年內”)之全年業績。 more info >> |
|
Friday, August 16, 2024 |
|
WL Delicious Announced 2024 Interim Results |
Weilong Delicious Global Holdings Ltd ('WL Delicious' ) and together with its subsidiaries (the Group) (Hong Kong stock code: 9985.HK) announced its unaudited interim results for the six months ended 30 June 2024. more info >> |
|
卫龙美味公布2024年中期业绩 |
中国辣味休闲食品行业龙头企业,卫龙美味全球控股有限公司(「卫龙美味」或「集团」)及附属公司(「集团」)(香港联交所股票代码:09985)公布截至2024年6月30日止六个月(「期内」)未经审核之中期业绩。 more info >> |
|
卫龙美味公佈2024年中期業績 |
中國辣味休閒食品行業龍頭企業,卫龙美味全球控股有限公司(「卫龙美味」或「集團」)及附屬公司(「集團」)(香港聯交所股票代碼:09985)公佈截至2024年6月30日止六個月(「期內」)未經審核之中期業績。 more info >> |
|
Thursday, March 21, 2024 |
|
卫龙美味公布2023年全年业绩 |
中国辣味休闲食品行业龙头企业,卫龙美味全球控股有限公司(「卫龙美味」或「集团」)及附属公司(「集团」)(香港联交所股票代码:09985)公布截至2023年12月31日止12个月(「年内」)之全年业绩。 more info >> |
|
卫龙美味公佈2023年全年業績 |
中國辣味休閒食品行業龍頭企業,卫龙美味全球控股有限公司(「卫龙美味」或「集團」)及附屬公司(「集團」)(香港聯交所股票代碼:09985)公佈截至2023年12月31日止12個月(「年內」)之全年業績。 more info >> |
|
WL Delicious Announced 2023 Annual Results |
Weilong Delicious Global Holdings Ltd ("WL Delicious" or the "Company") and together with its subsidiaries (the "Group") (Hong Kong stock code: 9985.HK) announced its audited annual results for the year ended 31 December 2023 ("Reporting Period"). more info >> |
|
Tuesday, August 29, 2023 |
|
卫龙公布2023年中期业绩 |
中国辣味休闲食品行业龙头企业,卫龙美味全球控股有限公司(「卫龙」或「集团」,香港联交所股票代码:09985)公布截至2023年6月30日止六个月(「期内」)未经审核之中期业绩。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Naoris Protocol Announces Upcoming TGE for $NAORIS
Jul 29, 2025 23:59: JST
|
|
|
Naoris Protocol Announces Upcoming TGE for $NAORIS
Jul 29, 2025 23:59 HKT/SGT
|
|
|
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Jul 29, 2025 23:39 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 29, 2025 23:13 HKT/SGT
|
|
|
GTJAI Achieved 'Carbon Neutrality' at Operational Level for the Third Consecutive Year
Jul 29, 2025 23:06 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Jul 29, 2025 20:00 JST
|
|
|
Wintermar Offshore (WINS:JK) Reports 1H2025 Results
Jul 29, 2025 18:56 HKT/SGT
|
|
|
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
|
|
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇樹衝刺IPO、機械人應用加速落地:首程控股雙輪驅動兌現紅利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇树冲刺IPO、机器人应用加速落地:首程控股双轮驱动兑现红利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
國泰君安國際連續第三年實現營運層面「碳中和」
Jul 29, 2025 11:19 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 9:01 JST
|
|
|
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|